Partnerships
Selected partnerships for scale
Sodium chloride is an established ingredient in respiratory self-care. BREATHOX® builds on that foundation through a differentiated, patented dry-powder inhalation technology. LIITA works with selected commercial, scientific and institutional partners to expand the reach and evidence base of the technology. We prioritise relationships that add relevant capabilities while preserving a coherent technology, evidence, intellectual-property and brand platform.
Commercial partnerships
BREATHOX® is commercialised through selected pharmacy and distribution relationships. LIITA works with partners that bring consumer-health expertise, market access and regulatory capabilities.
Clinical and scientific partnerships
LIITA collaborates with universities, hospitals, clinicians and specialist researchers to evaluate the technology and strengthen the evidence base for current and future applications.
Institutional and dual-use collaboration
LIITA engages with healthcare, defence and public-sector stakeholders where the platform offers a credible application or route to scale. Activities include Defence Tech Denmark and invited industry-expert participation in NATO Science and Technology Organization work on product-neutral respiratory research.